Is choice of antihypertensive agent important in improving cardiovascular outcomes in high-risk hypertensive patients?

about

Is choice of antihypertensive agent important in improving cardiovascular outcomes in high-risk hypertensive patients?

Item

http://www.wikidata.org/entity/Q35896630

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@ast

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@en

type

Item

label

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@ast

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@en

prefLabel

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@ast

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@en

P1476

Is choice of antihypertensive ...... gh-risk hypertensive patients?

@en

P2093

Jula K Inrig

http://www.w3.org/2001/XMLSchema#string

Robert D Toto

http://www.w3.org/2001/XMLSchema#string

P2860

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Global burden of hypertension: analysis of worldwide data

Selected major risk factors and global and regional burden of disease

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

P304

1000-1004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2009.08.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19782453

http://www.w3.org/2001/XMLSchema#string

P932

4517590

http://www.w3.org/2001/XMLSchema#string